期刊文献+

术前外周血血小板与淋巴细胞比值对非小细胞肺癌患者预后的影响 被引量:15

Effects of preoperative blood platelet-to-lymphocyte ratio on prognosis of non-small cell lung cancer patients after surgical resection
下载PDF
导出
摘要 目的:探讨术前外周血血小板与淋巴细胞比值(PLR)与非小细胞肺癌患者临床病理特征的相关性及其对患者预后的影响。方法:回顾性分析2004年1月至2007年12月在济宁医学院附属医院行根治性手术切除并经病理诊断明确的255例非小细胞肺癌患者的临床病理资料。以PLR中位数将患者分为低PLR组和高PLR组,分析PLR与患者临床病理因素的相关性,单因素及多因素生存分析评价PLR对患者术后生存的影响。结果:全组患者术前PLR为45.45~272.66,中位值为130。低PLR组(≤130)127例,高PLR组(〉130)128例,PLR与肿瘤部位、T分期及临床分期相关(均P〈0.05)。低PLR组和高PLR组患者的5年生存率分别为49.6%和33.6%,差异有统计学意义(P〈0.001);单因素分析结果显示:吸烟史、分化程度、临床分期、T分期、N分期、术后辅助治疗及PLR是患者预后的影响因素(均P〈0.05),多因素分析表明,N分期、术后辅助治疗及PLR是影响患者预后的独立危险因素(均P〈0.05)。分层分析显示,在无淋巴结转移及有淋巴结转移的患者中,低PLR与高PLR组患者的5年生存率差异均有统计学意义(P=0.020及0.037)。结论:术前PLR升高提示患者预后不良,是影响非小细胞肺癌患者预后的独立危险因素。 Objective:To investigate the correlation between preoperative blood platelet-to-lymphocyte ratio (PLR) and clinico-pathological features, as well as the effect of PLR on the prognosis of non-small cell lung cancer (NSCLC) patients after surgical resec-tion. Methods:Retrospective analysis was performed for 255 cases with histologically confirmed NSCLC that underwent curative re-section from January 2004 to December 2007. All patients were classified into two groups based on the median value of PLR. The rela-tionship between PLR and clinicopathological features was studied. Univariate and multivariate analyses were performed to assess the prognostic effect of preoperative PLR. Results:The median value of preoperative PLR was 130 (range:45.45 to 272.66). Based on the cut-off value of 130, all patients were divided into two groups:low PLR (≤130, n=127) and high PLR (〉130, n=128). PLR was corre-lated with tumor site, T stage, and clinical stage. Five-year survival rates of low and high PLR patients were 49.6%and 33.6%, respec-tively, which indicated a statistically significant difference (χ2=12.577, P〈0.001) between the two groups. Univariate analysis showed that smoking status, histological differentiation, clinical stage, T stage, N stage, postoperative adjuvant therapy and PLR were associat-ed with survival (P〈0.05 for all). Multivariate analysis identified N stage, postoperative adjuvant therapy, and PLR as independent prog-nostic factors of all the patients. In addition, stratified analysis showed that the five-year survival rate of the low PLR group was higher than that of the high PLR group with or without lymph node metastasis, and the differences were statistically significant (P=0.020 and 0.037). Conclusion:An elevated blood preoperative PLR indicates poor prognosis in NSCLC patients. Preoperative PLR is an indepen-dent prognostic factor of NSCLC after curative resection.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第21期1374-1378,共5页 Chinese Journal of Clinical Oncology
关键词 非小细胞肺癌 血小板与淋巴细胞比值 预后 non-small cell lung cancer platelet-to-lymphocyte ratio prognosis
  • 相关文献

参考文献16

  • 1Mantovani A,Allavena P,Sica A,et al.Cancer-related inflammation[J].Nature,2008,454(7203):436-444.
  • 2Colotta F,Allavena P,Sica A,et al.Cancer-related inflammation,the seventh hallmark of cancer:links to genetic instability[J].Carcinogenesis,2009,30(7):1073-1081.
  • 3Proctor MJ,Morrison DS,Talwar D,et al.A comparison of inflammation-based prognostic scores in patients with cancer.A Glasgow Inflammation Outcome Study[J].Eur J Cancer,2011,47(17):2633-2641.
  • 4Jeong JH,Lim SM,Yun JY,et al.Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer[J].Oncology,2012,83(5):292-299.
  • 5Jiang N,Deng JY,Liu Y,et al.The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer[J].Biomarkers,2014,19(6):444-451.
  • 6Kwon HC,Kim SH,Oh SY,et al.Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer[J].Biomarkers,2012,17(3):216-222.
  • 7Asher V,Lee J,Innamaa A,et al.Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer[J].Clin Transl Oncol,2011,13(7):499-503.
  • 8Sanchez-Lara K,Turcott JG,Juarez E,et al.Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer:a prospective study[J].Nutr Cancer,2012,64(4):526-534.
  • 9Unal D,Eroglu C,Kurtul N,et al.Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis[J]?Asian Pac J Cancer Prev,2013,14(9):5237-5242.
  • 10Kemal Y,Yucel I,Ekiz K,et al.Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis[J].Asian Pac J Cancer Prev,2014,15(6):2651-2654.

二级参考文献14

  • 1蒋晓婷,刘建栋,陶厚权.胃癌患者高血小板血症与预后关系的研究[J].中华普通外科杂志,2005,20(7):411-413. 被引量:23
  • 2Soonthornthum T,Suraseraneewong V,Kengsakol K,et al.Thrombocytosis in advanced epithelial ovarian cancer[J].J Med Assoc Thai,2007,90(8):1495-1500.
  • 3Tomita M,Shimizu T,Hara M,et al.Prognostic impact of thrombocytosis in resectable non-small cell lung cancer[J].Interact Cardiovasc Thorac Surg,2008,7(4):613-615.
  • 4Aoe K,Hiraki A,Ueoka H,et al.Thrombocytosis as a useful prognostic indicator in patients with lung cancer[J].Respiration,2004,71(2):170-173.
  • 5Cogus G,Baltaci S,Filiz E,et al.Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma[J].Urology,2004,63(3):447-450.
  • 6Bensalah K,Leray E,Fergelot P,et al.Prognostic value of thrombocytosis in renal cell carcinoma[J].J Urol,2006,175(3 Pt 1):859-863.
  • 7Ikeda M,Fttrukawa H,Imamura H,et al.Poor prognosis associated with thrombocytosis in patients with gastric cancer[J].Ann Surg Oncol,2002,9(3):287-291.
  • 8van Rossum AP,Vlasvdd LT,Vlasveld IN,et al.Granulocytosis and thrombocytosis in renal cell carcinoma:a pro-inflammatory cytokine response originating in the tumour[J].Neth J Med,2009,67(5):191-194.
  • 9Lin Y,Jia Z,Dong L,et al.A randomized pilot study of atractylenolide I on gastric cancer cachexia patients[J].Evid Based Gomplement Alternat Med,2008,5(3):337-344.
  • 10Lawicld S,Gzygier M,Wojtukiewicz M,et al.The plasma levels and diagnostic udlity of granulocyte-colony stimulating factor (G-GSF) and granulocyte-macrophage-colony stimulating factor (GM-GSF) in patients with Ⅰ and Ⅱ stage of breast cancer[J].Przegt Lek,2009,66(7):365-369.

共引文献4

同被引文献81

  • 1李晓宇,何兴祥.炎症与肿瘤的关系研究进展[J].广东医学,2006,27(9):1427-1428. 被引量:13
  • 2陈岳青,邹学森,黄秀珍,陈文学.非小细胞肺癌患者外周血T淋巴细胞亚群及NK细胞亚群分析及临床意义[J].实用癌症杂志,2006,21(5):476-478. 被引量:17
  • 3Zhang Y, Wang L, Liu Y, et al. Preoperative neutrophil- lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery [J]. Int J Gynecol Cancer, 2014,24(7):1319- 1325.
  • 4Mizunuma M, Yokoyama Y. The pretreatment neutrophil-to- lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer [ J ]. Int J Clin Dncol, 2015,20 ( 5 ) : 989 -996.
  • 5Warschkow R, Tarantino I, Ukegjini K, et al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery [J]. Langenbecks Arch Surg, 2012,397 (5): 727-736.
  • 6Dutta S, Going JJ, Crumley AB, et al. The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma [J]. Br J Cancer, 2012,106(4) :702-710.
  • 7Fridlender ZG, Sun J, Mishalian I, et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils [J]. PLoS One, 2012,7(2):e31524.
  • 8Lee YY, Choi CH, Kim HJ, et al. Pretreatment neutrophil: lymphocyte ratio as a prognostic factor in cervical carcinoma [J ]. Anticancer Res, 2012,32(4) : 1555-1561.
  • 9ZHANG X, CUI X,LI F, et al. Association between diabetesmellitus with metabolic syndrome and diabetic microangiopathy[J].Exp Ther Med, 2014,8(6) : 1867-1873.
  • 10MAY,YANG C,TAO Y,et al. Recent technologicaldevelopments in proteomics shed new light on translationalresearch on diabetic microangiopathy [J].FEBS J, 2013,280(22):5668-5681.

引证文献15

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部